Evonik expands AvailOm® high-load omega-3 powder platform

Specialty chemicals company, Evonik has expanded its AvailOm® platform of high-load omega-3 powders to help nutraceutical companies develop superior algal or fish-oil based formulations of their dietary supplements. Each of the three grades can address the lifestyle needs of consumer groups, such as vegans and vegetarians, or specific application areas such as healthy ageing, pregnancy and maternity.

AvailOm® is the highest-load platform of omega-3 powders in its class with 50% EPA and DHA (refer to footnote) as a free fatty acid by weight, giving it a bioavailability more than five times higher than traditional omega-3 fish oil soft-gel capsules. Being directly compressible into tablets and with an oxidation resistance of more than four years, AvailOm® enables the development of pure or multi-product combination supplements with omega-3 that are more convenient and easier to swallow. It can also prevent side-effects associated with fish oil capsules including undesirable smells and aftertaste, or fishy burps.

“AvailOm® highlights Evonik’s commitment to the development of advanced food ingredients that are sustainable and scientifically proven to improve health and overall quality of life,” said Cornelis van den Muyzenberg, Vice President Food Ingredients and Strategic Projects. “We look forward to leveraging our AvailOm® platform, as well as our complementary formulation and scale-up services, to help nutraceutical customers create differentiated supplement brands that are safe, convenient and comfortable for consumers to take as part of their normal daily routine.” 

“With this expansion of our AvailOm® platform, nutraceutical companies can further differentiate their supplement brands by selecting from one of three separate grades that are each tailored to specific consumer groups or health areas,” said Dr. Christopher Studte, Director New Health Ingredients at Evonik. “In addition to the provision of guidelines that can help optimize the use and handling of AvailOm®, a range of formulation development and scale-up services are available to help customers accelerate their speed to market.”

AvailOm® 50 High DHA Algae has a higher concentration of the type of omega-3 known as docosahexaenoic acid (DHA), which is associated with infant development, eye health and cognition function. Being derived from algal sources, it is ideal for use by vegans and vegetarians, especially during pregnancy or early motherhood.

An additional fish-oil based DHA grade known as AvailOm® 50 High DHA is also available. AvailOm® 50 High EPA has a higher concentration of the type of omega-3 known as eicosapentaenoic acid (EPA), which is associated with heart and joint health as well as reduced inflammation, making it ideal for consumers seeking supplements that support healthy ageing.

All grades of AvailOm® are sustainably sourced to protect not only fish and krill, but other marine life that depend upon them.

Webinar

Evonik will host a free webinar on best practices and emerging trends in the formulation of combination products with omega-3 on Thursday, October 8 at 10:00 a.m. EDT / 4:00 p.m. CEST. For more information and to register, click here.

About AvailOm®

AvailOm® utilizes a proprietary process to combine free fatty acids and essential amino acids to form a solid omega-3 lysine complex with unmatched properties. This technology allows EPA and DHA to be readily absorbed without any requirement for the body to break down ethyl ester or triglyceride forms for their uptake. AvailOm® is cleared for marketing within Europe and the U.S as well as many other countries. For further product or regulatory information on AvailOm®, contact Evonik at healthcare@evonik.com.